|
| 36702499 | Connectomic Basis for Tremor Control in Stereotactic Radiosurgical Thalamotomy. | AJNR Am J Neuroradiol | 2023 |
| 37563079 | Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort. | Parkinsonism Relat Disord | 2023 |
| 37632656 | Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. | Neurol Ther | 2023 |
| 38052871 | Population fraction of Parkinson's disease attributable to preventable risk factors. | NPJ Parkinsons Dis | 2023 |
| 38045566 | Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptoms. | Clin Park Relat Disord | 2023 |
| 37877478 | Cost-Effectiveness of Carbidopa-Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States. | Mov Disord | 2023 |
| 37817017 | Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. | Neurol Ther | 2023 |
| 37334615 | What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP). | J Parkinsons Dis | 2023 |
| 37302039 | Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results. | J Parkinsons Dis | 2023 |
| 37365181 | Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease. | Nat Commun | 2023 |
| 37398408 | Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations. | medRxiv | 2023 |
| 37292848 | Population fraction of Parkinson's disease attributable to preventable risk factors. | medRxiv | 2023 |
| 36853618 | Brain and Systemic Inflammation in De Novo Parkinson's Disease. | Mov Disord | 2023 |
| 36803825 | Disease mechanisms as subtypes: Inflammation in Parkinson disease and related disorders. | Handb Clin Neurol | 2023 |
| 36495691 | Unaltered T cell responses to common antigens in individuals with Parkinson's disease. | J Neurol Sci | 2023 |
| 35139431 | Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia. | Neurobiol Dis | 2022 |
| 35707825 | John Q. Trojanowski, MD, PhD (1946-2022). | Mov Disord | 2022 |
| 35379749 | RORγt-Expressing Pathogenic CD4<sup>+</sup> T Cells Cause Brain Inflammation during Chronic Colitis. | J Immunol | 2022 |
| 35626315 | Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method. | Diagnostics (Basel) | 2022 |
| 35446614 | Alpha-synuclein-mediated DNA damage, STING activation, and neuroinflammation in Parkinson's disease. | Proc Natl Acad Sci U S A | 2022 |
| 36402160 | Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. | Lancet Neurol | 2022 |
| 35964203 | Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up. | J Parkinsons Dis | 2022 |
| 36376318 | Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms. | Nat Commun | 2022 |
| 35314697 | Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures. | NPJ Parkinsons Dis | 2022 |
| 35012605 | Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain. | Mol Neurodegener | 2022 |
| 34974438 | Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel. | J Parkinsons Dis | 2022 |
| 35304493 | The emerging postural instability phenotype in idiopathic Parkinson disease. | NPJ Parkinsons Dis | 2022 |
| 32357266 | Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease. | Mov Disord | 2021 |
| 33850148 | Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease. | NPJ Parkinsons Dis | 2021 |
| 33649343 | The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. | NPJ Parkinsons Dis | 2021 |
| 33897612 | Gene-Environment Interactions in Progressive Supranuclear Palsy. | Front Neurol | 2021 |
| 33704423 | CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease. | Brain | 2021 |
| 33857722 | Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysis. | Parkinsonism Relat Disord | 2021 |
| 34408160 | Exploring human-genome gut-microbiome interaction in Parkinson's disease. | NPJ Parkinsons Dis | 2021 |
| 34464454 | Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy. | Clin Pharmacol Ther | 2021 |
| 34695657 | Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. | Parkinsonism Relat Disord | 2021 |
| 34631942 | DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease. | Mov Disord Clin Pract | 2021 |
| 34301818 | Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease. | Neurol Neuroimmunol Neuroinflamm | 2021 |
| 33972291 | Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau. | eNeuro | 2021 |
| 33432042 | The TCR repertoire of α-synuclein-specific T cells in Parkinson's disease is surprisingly diverse. | Sci Rep | 2021 |
| 32220093 | Progressive Supranuclear Palsy and Statin Use. | Mov Disord | 2020 |
| 31993745 | T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. | Acta Neuropathol | 2020 |
| 31837424 | Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions. | Neurobiol Dis | 2020 |
| 31958097 | Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person. | J Parkinsons Dis | 2020 |
| 32098856 | Defining research priorities in dystonia. | Neurology | 2020 |
| 31710391 | Bridging the gaps: More inclusive research needed to fully understand Parkinson's disease. | Mov Disord | 2020 |
| 32102975 | Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? | Neurology | 2020 |
| 33163560 | Brain Alchemy: Transforming Astrocytes into Neurons for Neurodegenerative Disease. | Mov Disord Clin Pract | 2020 |
| 32731191 | Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. | Parkinsonism Relat Disord | 2020 |
| 32873195 | Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE. | Neurodegener Dis Manag | 2020 |